Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Acme United	ACU	20. nov 2024	41.39	-0.41
ACNB	ACNB	20. nov 2024	47.17	+0.08
ACRES Commercial Realty	ACR	20. nov 2024	16.74	+0.60
ACRES Commercial Realty C Pref	ACR-C	20. nov 2024	25.14	+0.46
ACRES Commercial Realty D Pref	ACR-D	20. nov 2024	23.08	-0.86
Acrivon Therapeutics	ACRV	20. nov 2024	6.50	+1.88
Actelis Networks	ASNS	20. nov 2024	1.19	-1.65
Actinium Pharmaceuticals	ATNM	20. nov 2024	1.39	-2.11
Active Bear ETF	HDGE	20. nov 2024	17.53	-0.86
Active U.S. Real Estate Powershares	PSR	20. nov 2024	96.21	-0.50
Actuate Therapeutics	ACTU	20. nov 2024	8.58	-3.60
Acuity Brands	AYI	20. nov 2024	315.62	-0.42
Acumen Pharmaceuticals	ABOS	20. nov 2024	2.37	-0.84
Acurx Pharmaceuticals	ACXP	20. nov 2024	1.39	-16.77
Acushnet	GOLF	20. nov 2024	69.10	-0.16
ACV Auctions A	ACVA	20. nov 2024	21.37	-0.42
ACWI Ex-US Index MSCI Ishares	ACWX	20. nov 2024	53.61	-0.22
ACWI Index MSCI Ishares	ACWI	20. nov 2024	119.56	0.00
Adagene ADR	ADAG	20. nov 2024	2.09	-5.86
Adagio Medical	ADGM	20. nov 2024	2.00	-18.03
Adams Diversified Equity Fund	ADX	20. nov 2024	22.30	-1.02
Adams Natural Resources Fund	PEO	20. nov 2024	24.36	+0.66
Adams Resources & Energy	AE	20. nov 2024	37.15	-0.13
AdaptHealth	AHCO	20. nov 2024	9.72	-0.21
Adaptimmune Therapeutics ADR	ADAP	20. nov 2024	0.66	-1.50
Adaptive Biotechnologies	ADPT	20. nov 2024	4.42	-1.34
ADC Therapeutics SA	ADCT	20. nov 2024	1.98	-3.88
Addentax Group	ATXG	20. nov 2024	0.56	+1.43
Addex Therapeutics ADR	ADXN	20. nov 2024	7.38	-7.40
Addus HomeCare	ADUS	20. nov 2024	120.99	+0.66

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.